VIRIOS THERAPEUTICS INC (VIRI)
US92829J1043 - Common Stock
| MRQ (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 3.02M | 3.32M | 7.03M | 14.01M | 29.80M | |||
| Other Current Assets | 615.70K | 848.50K | 1.34M | 1.77M | 1.68M | |||
| Total Current Assets | 3.64M | 4.17M | 8.37M | 15.78M | 31.47M | |||
| Non-Current Assets | ||||||||
| Other Non-Current Assets | N/A | N/A | N/A | N/A | N/A | |||
| Total Non-Current Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| TOTAL ASSETS | 3.64M | 4.17M | 8.37M | 15.78M | 31.47M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 282.31K | 246.64K | 470.00K | 920.00K | 1.16M | |||
| Accounts Payable | 217.76K | 111.91K | 570.00K | 350.00K | 370.00K | |||
| Total Current Liabilities | 500.08K | 358.55K | 1.04M | 1.28M | 1.53M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Total Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| TOTAL LIABILITIES | 500.08K | 358.55K | 1.04M | 1.28M | 1.53M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -63.81M | -61.47M | -56.17M | -43.93M | -27.97M | |||
| Additional Paid In Capital | 67.24M | 65.57M | 63.50M | 58.43M | 57.91M | |||
| Common Shares | 2.78K | 1.93K | 0.00 | 0.00 | 0.00 | |||
| Treasury Stock | -299.11K | -299.11K | N/A | N/A | N/A | |||
| Shares Outstanding | 27.76M | 19.26M | 18.33M | 8.33M | 8.31M | |||
| Tangible Book Value per Share | 0.11 | 0.20 | 0.40 | 1.74 | 3.60 | |||
| Total Shareholders' Equity | 3.14M | 3.81M | 7.33M | 14.50M | 29.94M | |||
| TOTAL LIABILITIES AND EQUITY | 3.64M | 4.17M | 8.37M | 15.78M | 31.47M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 7.27 | 11.62 | 8.05 | 12.33 | 20.57 | |||
| Return On Assets (ROA) | -145.66% | -127.14% | -146.36% | -101.14% | -32.89% | |||
| Return On Equity (ROE) | -168.89% | -139.12% | -167.12% | -110.07% | -34.57% | |||
All data in USD , ROIC based on taxRate of 0.21